/
NVNO
$10.86-$0.13 (-1.23%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$7.5M
1M shares
52-week range
$8.67 – $178.15
1% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Change$-347.54
enVVeno Medical Corporation Common Stock
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
www.envveno.com- Employees
- 33
- IPO / List date
- May 31, 2018
- HQ
- IRVINE, CA
Held by traders on TradeandTell
No one on the platform currently holds NVNO.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in NVNO as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-01-20 | 1-for-35reverse |
| 2020-11-30 | 1-for-25reverse |
Recent trades on TradeandTell
No one on the platform has traded NVNO yet.
